» Articles » PMID: 7890425

Cytokine MRNA Profiles in Mononuclear Cells in Acute Aseptic Meningoencephalitis

Overview
Journal Infect Immun
Date 1995 Apr 1
PMID 7890425
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Cytokines are important modulators of inflammation and immune responses. Using in situ hybridization with radiolabelled cDNA oligonucleotide probes, we studied the expression of mRNA encoding the cytokines gamma interferon (IFN-gamma), interleukin 4 (IL-4), IL-6, IL-10, transforming growth factor beta (TGF-beta), tumor necrosis factor alpha (TNF-alpha), lymphotoxin, and perforin in mononuclear cells (MNC) from blood and cerebrospinal fluid (CSF) of patients with acute aseptic meningoencephalitis (AM) and from blood of healthy controls. Patients in the acute phase of AM had elevated numbers of IFN-gamma mRNA-expressing cells in the blood compared with that of controls and higher numbers of IFN-gamma mRNA-expressing cells in their CSF compared with that of convalescent-phase patients, which is in accordance with the antiviral effects of this cytokine. Upregulation of IL-4, IL-6, and IL-10 was found in convalescent-phase patients, which is consistent with the longstanding B-cell response found in AM. TGF-beta and perforin were upregulated in both stages of AM, while the numbers of blood and CSF MNC expressing cytokine mRNA of the TNF family (TNF-alpha and lymphotoxin) did not differ between patients with AM and controls. An even higher elevation in CSF was noticed for MNC expressing most of the cytokines, particularly IL-4 and TGF-beta, reflecting the autonomy of the immune response in the CSF. The definition of cytokine profiles in AM, a self-limiting and benign disease, provides a foundation for future comparisons with other infectious and inflammatory nervous system diseases.

Citing Articles

IL-15 mRNA expression is up-regulated in blood and cerebrospinal fluid mononuclear cells in multiple sclerosis (MS).

Kivisakk P, Matusevicius D, He B, Soderstrom M, Fredrikson S, Link H Clin Exp Immunol. 1998; 111(1):193-7.

PMID: 9472681 PMC: 1904841. DOI: 10.1046/j.1365-2249.1998.00478.x.

References
1.
Kuruvilla A, Shah R, Hochwald G, Liggitt H, Palladino M, Thorbecke G . Protective effect of transforming growth factor beta 1 on experimental autoimmune diseases in mice. Proc Natl Acad Sci U S A. 1991; 88(7):2918-21. PMC: 51351. DOI: 10.1073/pnas.88.7.2918. View

2.
Poli G, Kinter A, Justement J, Bressler P, Kehrl J, Fauci A . Transforming growth factor beta suppresses human immunodeficiency virus expression and replication in infected cells of the monocyte/macrophage lineage. J Exp Med. 1991; 173(3):589-97. PMC: 2118806. DOI: 10.1084/jem.173.3.589. View

3.
Jacobs R, Tabor D . The immunology of sepsis and meningitis--cytokine biology. Scand J Infect Dis Suppl. 1990; 73:7-15. View

4.
Minamishima I, Ohga S, Ishii E, Miyazaki C, Hamada K, Akazawa K . Aseptic meningitis in children: correlation between fever and interferon-gamma level. Eur J Pediatr. 1991; 150(10):722-5. DOI: 10.1007/BF01958764. View

5.
Stitz L, Planz O, Bilzer T, Frei K, Fontana A . Transforming growth factor-beta modulates T cell-mediated encephalitis caused by Borna disease virus. Pathogenic importance of CD8+ cells and suppression of antibody formation. J Immunol. 1991; 147(10):3581-6. View